Researchers at Stanford University and Peking University have developed PAGERs, a modular system that allows for the creation of customizable GPCRs responsive to various ligands.
This new technology builds on DREADDs, which are synthetic GPCRs activated by a specific drug, widely used in neuroscience to dissect brain circuits.
Collection
[
|
...
]